Pfizer is poised to start selling Inflectra, its version of the blockbuster rheumatoid arthritis drug Remicade. But the price of Inflectra is only 15 percent less.
A voucher awarded to a company that finds a treatment for a rare childhood disease can be sold to the highest bidder and then used to fast-track the review of another drug. Are the prizes worth it?
About 27 percent of Food and Drug Administration reviewers who approved hematology-oncology drugs from 2001 through 2010 left to work for the industry they previously regulated, an analysis found.
The Food and Drug Administration approved a muscular dystrophy drug despite deeply flawed evidence. Was the decision a dangerous precedent or flexible pragmatism reflecting patients' values?
Clinics are using stem cells to treat problems ranging from arthritis and torn tendons to paralysis and stroke. But researchers say there's no evidence that the treatments work or are safe.
Four years after user fees were imposed to speed up the review of generic drug applications by the Food and Drug Administration, more than 4,000 generics remain in limbo.
The recommendations from the Food and Drug Administration represent a major expansion in testing blood for Zika. The agency had earlier advised testing only in areas with an active outbreak.
The Food and Drug Administration has approved release of genetically engineered mosquitoes in an effort to halt the spread of Zika virus. But residents of the Florida Keys aren't keen on the concept.
For its latest anti-tobacco campaign, the Food and Drug Administration wants to harness hip-hop swagger to reach minority teens — who disproportionately suffer the consequences of smoking.